Jefferies Maintains Bullish Stance on Gen-Probe (GPRO) After Survey
Tweet
Share
E-mailGet Alerts GPRO Hot Sheet
Price: $0.60 --0%
Rating Summary:
4 Buy, 11 Hold, 6 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 19
Rating Summary:
4 Buy, 11 Hold, 6 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 19
Join SI Premium – FREE
Jefferies reiterated their Buy rating and $78 price target on Gen-Probe (NASDAQ: GPRO) following recent interviews with more than 25 private & public labs in the US to gauge customer reception towards GPRO's new assays, as well as pre-market orientation around PANTHER.
"Our diligence uncovered evidence of stronger than anticipated interest in both GPRO's Trich & HPV assays that we estimate could lead to upwards of $0.05 (+2%) and $0.15 (+5%) of EPS upside in 2012 & 2013, respectively," the firm said.
For an analyst ratings summary and ratings history on Gen-Probe click here. For more ratings news on Gen-Probe click here.
Shares of Gen-Probe closed at $65.07 yesterday.
"Our diligence uncovered evidence of stronger than anticipated interest in both GPRO's Trich & HPV assays that we estimate could lead to upwards of $0.05 (+2%) and $0.15 (+5%) of EPS upside in 2012 & 2013, respectively," the firm said.
For an analyst ratings summary and ratings history on Gen-Probe click here. For more ratings news on Gen-Probe click here.
Shares of Gen-Probe closed at $65.07 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ADC Therapeutics (ADCT) PT Lowered to $5 at Guggenheim
- Gemini Space Station (GEMI) PT Lowered to $6 at Needham
- Enhanced Group Inc. (ENHA) PT Lowered to $5 at Canaccord
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
